Editorial: The NeuroCOVID-19 syndrome: cognitive and psychological profiles, physiopathology, and impact on neurologically vulnerable populations.
作者信息
Jose Caroline, Rudroff Thorsten, Chamard-Witkowski Ludivine
机构信息
Centre de Médecine de Précision, Centre Hospitalier Universitaire Georges-L.-Dumont, Réseau de Santé Vitalité, Moncton, NB, Canada.
Département de Médecine de Famille et de Médecine d'urgence, Faculté des Sciences de la Santé, Université de Sherbrooke, Sherbrooke, QC, Canada.
出版信息
Front Neurol. 2024 Jul 19;15:1452895. doi: 10.3389/fneur.2024.1452895. eCollection 2024.
Abstract
摘要
相似文献
1
Editorial: The NeuroCOVID-19 syndrome: cognitive and psychological profiles, physiopathology, and impact on neurologically vulnerable populations.社论：神经新冠综合征：认知与心理特征、生理病理学及其对神经脆弱人群的影响
Front Neurol. 2024 Jul 19;15:1452895. doi: 10.3389/fneur.2024.1452895. eCollection 2024.
2
The Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Development of Case Report Forms for Global Use.新型冠状病毒相关神经功能障碍全球联合会研究（GCS-NeuroCOVID）：全球使用病例报告表的制定。
Neurocrit Care. 2020 Dec;33(3):793-828. doi: 10.1007/s12028-020-01100-4. Epub 2020 Sep 18.
3
Long-term outcomes after NeuroCOVID: A 6-month follow-up study on 60 patients.NeuroCOVID 后长期预后：60 例患者 6 个月随访研究。
Rev Neurol (Paris). 2022 Jan-Feb;178(1-2):137-143. doi: 10.1016/j.neurol.2021.12.008. Epub 2022 Jan 6.
4
Spectrum of hospitalized NeuroCOVID diagnoses from a tertiary care neurology centre in Eastern India.印度东部一家三级护理神经病学中心收治的神经 COVID 诊断范围。
J Clin Neurosci. 2021 Nov;93:96-102. doi: 10.1016/j.jocn.2021.09.008. Epub 2021 Sep 15.
5
Markers of blood-brain barrier disruption increase early and persistently in COVID-19 patients with neurological manifestations.标志物的血脑屏障破坏增加早，持续在 COVID-19 患者有神经症状。
Front Immunol. 2022 Dec 15;13:1070379. doi: 10.3389/fimmu.2022.1070379. eCollection 2022.
6
Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes.严重急性呼吸综合征冠状病毒 2 患者急性神经系统综合征的脑脊液生物标志物。
Rev Neurol (Paris). 2023 Mar;179(3):208-217. doi: 10.1016/j.neurol.2022.11.002. Epub 2022 Nov 30.
7
Cognitive dysfunctions in the course of SARS‑CoV‑2 virus infection, including NeuroCOVID, frontal syndrome and cytokine storm (Review).严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染过程中的认知功能障碍，包括神经型冠状病毒病、额叶综合征和细胞因子风暴（综述）
Biomed Rep. 2024 May 16;21(1):103. doi: 10.3892/br.2024.1791. eCollection 2024 Jul.
8
Global Consortium Study of Neurological Dysfunction in COVID-19 (GCS-NeuroCOVID): Study Design and Rationale.全球 COVID-19 相关神经功能障碍合作研究（GCS-NeuroCOVID）：研究设计与原理。
Neurocrit Care. 2020 Aug;33(1):25-34. doi: 10.1007/s12028-020-00995-3.
9
Emerging potential mechanisms and predispositions to the neurological manifestations of COVID-19.新型冠状病毒肺炎（COVID-19）神经表现的潜在机制及易感性
J Neurol Sci. 2021 Sep 15;428:117608. doi: 10.1016/j.jns.2021.117608. Epub 2021 Aug 4.
10
The European Academy of Neurology NeuroCOVID-19 Task Force: A lesson for the future.欧洲神经病学学会新型冠状病毒肺炎特别工作组：未来之鉴。
Eur J Neurol. 2025 Jan;32(1):e16321. doi: 10.1111/ene.16321. Epub 2024 Apr 26.
本文引用的文献
1
Breaking through the noise: how to unveil the cognitive impact of long COVID on pre-existing conditions with executive dysfunctions?突破噪音：如何揭示长期新冠对存在执行功能障碍的既往病症的认知影响？
Front Psychiatry. 2024 May 23;15:1390214. doi: 10.3389/fpsyt.2024.1390214. eCollection 2024.
2
The knowns and unknowns of long COVID-19: from mechanisms to therapeutical approaches.长新冠的已知与未知：从发病机制到治疗方法。
Front Immunol. 2024 Mar 4;15:1344086. doi: 10.3389/fimmu.2024.1344086. eCollection 2024.
3
NeuroCOVID: it's time to join forces globally.神经新冠：是时候全球携手合作了。
Lancet Neurol. 2020 Oct;19(10):805-806. doi: 10.1016/S1474-4422(20)30322-7. Epub 2020 Sep 16.
4
Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China.中国武汉住院的 2019 年冠状病毒病患者的神经系统表现。
JAMA Neurol. 2020 Jun 1;77(6):683-690. doi: 10.1001/jamaneurol.2020.1127.
Zotero 插件